BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Reports PharmTrain projects

Participants of the symposium: PharmTrain2 project staff together with management as well as technical partners from FDA Ghana

September 2024

Symposium of the GHPP PharmTrain2 project with FDA Ghana in Accra
to the report

A warm welcome to the Biosimilar Fellows from both the trainers of the Unit 35 and the GHPP PharmTrain team at BfArM

June 2024

Intensive biosimilar workshop fosters learning and networking
to the report

The fellows of the clinical fellowship program arrived at the workshop in Bonn almost in time for the cherry blossom
April 2024
Workshop at BfArM – Spotlight on pharmacokinetics
to the report
Biosimilar fellowship group picture
October/November 2023
Biosimilar-fellows visit BfArM for the first time
to the report
ZaZiBoNa in Cape Town
October 2023
Premiere: training manual in action at ZaZiBoNa session
to the report
Fellows of the Clinical Fellowship meet the GHPP PharmTrain team at BfArM
June 2023
PharmTrain2 fellowship workshop: together towards clinical expertise
to the report
Group picture: BfArM president, TWG-MAG members, PharmTrain team, and WHO and BfArM experts
March 2023
Workshop - joint guideline development for West Africa and beyond
to the report
Project partners from the various international and regional partner organizations, leaders of current and future partner authorities as well as representatives of the individual working groups
November 2022
Longstanding partnerships and joint plans for the future: the PharmTrain event in Accra
to the report
The PharmTrain Fellows meet the Director of the European Medicines Agency (EMA), Ms. Emer Cooke and the Institute President, Professor Dr. Karl Broich, during her visit to the BfArM
October 2022
GHPP-PharmTrain fellowship: training in clinical assessment of medicinal products at the BfArM
to the report
As TWG-MAG members, the four national drug regulatory authorities of Ghana (FDA Ghana), Liberia (LMHRA), Sierra Leone (PBSL) and Gambia (MCA Gambia) are developing guidelines for drug approval together with the PharmTrain team
September 2022
GHPP PharmTrain workshop – target met: eight jointly developed regulatory guidelines are available online now
to the report